High prevalence of overweight, obesity, and hypertension with increased risk to cardiovascular disorders among adults in northwest Ethiopia: a cross sectional study

BMC Cardiovascular Disorders

Afework Kassu⁴  Bereket Fantahun²  Bemnet Amare¹  Beyene Moges³ 

[1] Department of Biochemistry, School of Medicine, College of Medicine and Health Sciences, University of Gondar, Gondar, Ethiopia;Department of Pediatrics, Addis Ababa University, Addis Ababa, Ethiopia;Department of Immunology and Molecular Biology, School of Biomedical and Laboratory Sciences, College of Medicine and Health Sciences, University of Gondar, Gondar, Ethiopia;Department of Medical Microbiology, School of Biomedical and Laboratory Sciences, College of Medicine and Health Sciences, University of Gondar, Gondar, Ethiopia

关键词: Ethiopia;    Anthropometry;    Hypertension;    Metabolic disorder;    Overweight;    Obesity;   

Others  :  1088711
DOI  :  10.1186/1471-2261-14-155

 received in 2014-01-04, accepted in 2014-10-27,  发布年份 2014

【 摘 要 】

Background

Overweight and obesity are components of a defined cluster of risk factors for non-communicable diseases, once problems for only the high-income countries, in recent days became rampant in developing countries. Despite the lack of extensive data on metabolic and cardio vascular disorders in Ethiopia, the prevalence of obesity among young adults (15–24 years), in a cross sectional study conducted in 1997, was 0.7% for men and 6% for women. The prevalence of hypertension (HTN) was found to be 7.1% of the population. The objective of this study was to see the prevalence and association of overweight, obesity and HTN and to check if there was any agreement among the various anthropometric measurements in detecting overweight and obesity.

Methods

This cross-sectional study was conducted in Gondar city, Northwest Ethiopia. A total of 68 participants with age >18 year were randomly selected and included. Data were collected using questionnaires and through physical measurements of weight, height and blood pressure, using the WHO recommendations.

Result

The prevalence of hypertension was 13.3% (9/68). The prevalence of overweight based on calculated body mass index (BMI) was 32.4% (22/68) while the prevalence of obesity was 16.2% (11/68). Body fat percentage (BFP) effectively classified all of the ‘overweight’ and ‘obese’ values according to the BMI as ‘overweight/obese’ (P = 0.016). Risk level classification with waist circumference enabled to correctly classify most (90.9%) and all of the ‘overweight’ and ‘obese’ BMI values as ‘increased risk/substantially increased risk’ (P < 0.001). Similarly, waist-to-height ratio (WHtR) was able to classify all ‘overweight’ and ‘obese’ BMI values as ‘increased risk/substantially increased risk’ (P < 0.001).

Conclusion

In conclusion, the current study was able to detect a high prevalence of overweight, obesity, and HTN among adult population in Gondar town. There is a prevalent high level of general adiposity and central obesity. WHtR and BFP were the most efficient measurements to identify all ‘high risk’ groups of individuals as ‘high risk’ irrespective of their gender. Further study is recommended to elucidate the risk factors and complications of obesity and overweight in the study area and beyond.

【 授权许可】

   
2014 Moges et al.; licensee BioMed Central Ltd.

【 参考文献 】

• [1]Santulli G: Epidemiology of cardiovascular disease in the 21st century: updated numbers and updated facts. JCvD 2013, 1(1):1-2.
• [2]Lim SS, Vos T, Flaxman AD, Danaei G, Shibuya K, Adair-Rohani H, Amann M, Anderson HR, Andrews KG, Aryee M, Atkinson C, Bacchus LJ, Bahalim AN, Balakrishnan K, Balmes J, Barker-Collo S, Baxter A, Bell ML, Blore JD, Blyth F, Bonner C, Borges G, Bourne R, Boussinesq M, Brauer M, Brooks P, Bruce NG, Brunekreef B, Bryan-Hancock C, Bucello C, et al.: A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990–2010: a systematic analysis for the Global Study 2010. Lancet 2012, 380(9859):2224-2260.
• [3]World Health Organization (WHO): Global Status Report on Noncommunicable Diseases 2010. Geneva: World Health Organization; 2011.
• [4]World Health Organization (WHO): Global Health Observatory Data Repository. Geneva: World Health Organization; 2008. [http://apps.who.int/gho/data/view.main webcite]
• [5]Ten Facts on Obesity. [http://www.who.int/features/factfiles/obesity/en/ webcite]
• [6]World Health Organization (WHO): Obesity: Preventing and Managing the Global Epidemic. WHO Technical Report Series No. 894. Geneva: WHO; 2000.
• [7]Betre M, Kebede D, Kassaye M: Modifiable risk factors for coronary heart disease among young people in Addis Ababa. East Afr Med J 1997, 74:376-381.
• [8]Tesfaye F, Byass P, Wall S: Population based prevalence of high blood pressure among adults in Addis Ababa: uncovering a silent epidemic. BMC Cardiovasc Disord 2009, 9:39. BioMed Central Full Text
• [9]Margaret A, Shiun DH: Six reasons why the waist-to-height ratio is a rapid and effective global indicator for health risks of obesity and how its use could simplify the international public health message on obesity. Int J Food Sci Nutr 2005, 56(5):303-307.
• [10]Lee CM, Huxley RR, Wildman RP, Woodward M: Indices of abdominal obesity are better discriminators of cardiovascular risk factors than BMI: a meta-analysis. J Clin Epidemiol 2008, 61:646-653.
• [11]Bemnet A, Beyene M, Feleke M, Bereket F, Mengesha A, Andargachew M, Afework K: Nutritional status and dietary intake of urban residents in Gondar, Northwest Ethiopia. BMC Public Health 2012, 12:752. BioMed Central Full Text
• [12]World Health Organization (WHO): Definition, Diagnosis and Classification of Diabetes Mellitus and its complications. Part 1: Diagnosis and Classification of Diabetes Mellitus. Provisional Report of a WHO Consultation. Geneva: WHO; 1999.
• [13]Gallagher D, Heymsfield SB, Heo M, Jebb SA, Murgatroyd PR, Sakamoto Y: Healthy percentage body fat ranges: an approach for developing guidelines based on body mass index1–3. Am J Clin Nutr 2000, 72:694-701.
• [14]Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, Jones DW, Materson BJ, Oparil S, Wright JT Jr, Roccella EJ, National Heart, Lung, and Blood Institute Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: The seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: The JNC 7 Report. JAMA 2003, 289:2560-2572.
• [15]World Health Organization (WHO): Noncommunicable Diseases Country Profiles 2011. Geneva: World Health Organization; 2011.
• [16]World Health Organization (WHO): Global Health Risks: Mortality and Burden Of Disease Attributable To Selected Major Risks. Geneva: World Health Organization; 2009.
• [17]World Health Organization (WHO): Global Strategy for Prevention and Control of Noncommunicable Diseases. Geneva: World Health Organization; http://www.who.int/nmh/publications/wha_resolution53_14/en/ webcite
• [18]Political Declaration of the High-Level Meeting of the General Assembly on the Prevention and Control of Noncommunicable Diseases. New York, 2011: United Nations General Assembly; 2011. A/66/L.1
• [19]World Health Organization (WHO): Draft Action Plan for the Prevention and Control of Noncommunicable Diseases 2013–2020. World Health Organization; http://www.who.int/nmh/events/2013/consultation_201303015/en/ webcite
• [20]Tesfaye F, Nawi NG, Van Minh H, Byass P, Berhane Y, Bonita R, Wall S: Association between body mass index and blood pressure across three populations in Africa and Asia. J Hum Hyper 2007, 21:28-37.
• [21]Alwan A, MacLean DR, Riley LM, d’Espaignet ET, Mathers CD, Stevens GA, Bettcher D: Monitoring and surveillance of chronic non-communicable diseases: progress and capacity in high-burden countries. Lancet 2010, 376(9755):1861-1868.
• [22]Brown CD, Higgins M, Donato KA, Rohde FC, Garrison R, Obarzanek E, Ernst ND, Horan M: Body mass index and the prevalence of hypertension and dyslipidemia. Obes Res 2000, 8:605-619.
• [23]Guh D, Zhang W, Bansback N, Amarsi Z, Birmingham CL, Anis AH: The incidence of co-morbidities related to obesity and overweight: a systematic review and meta-analysis. BMC Public Health 2009, 9:88. BioMed Central Full Text
• [24]Lamon-Fava S, Wilson PW, Schaefer EJ: Impact of body mass index on coronary heart disease risk factors in men and women. The Framingham Offspring Study. Arterioscler Thromb Vasc Biol 1996, 16:1509-1515.
• [25]Wilson P, d’Agostino R, Sullivan L, Parise H, Kannel W: Overweight and obesity as determinants of cardiovascular risk: the Framingham experience. Arch Intern Med 2002, 162:1867-1872.
• [26]Huang Z, Willett WC, Colditz GA, Hunter DJ, Manson JE, Rosner B, Speizer FE, Hankinson SE: Waist circumference, waist:hip ratio, and risk of breast cancer in the Nurses’ Health Study. Am J Epidemiol 1999, 150:1316-1324.
• [27]Huxley R, Mendis S, Zheleznyakov E, Reddy S, Chan J: Body mass index, waist circumference and waist:hip ratio as predictors of cardiovascular risk–a review of the literature. Eur J Clin Nutr 2010, 64:16-22.
• [28]Visscher TL, Seidell JC, Molarius A, van der Kuip D, Hofman A, Witteman JC: A comparison of body mass index, waist-hip ratio and waist circumference as predictors of all-cause mortality among the elderly: the Rotterdam study. Int J Obes Relat Metab Disord 2001, 25:1730-1735.
• [29]de Koning L, Merchant A, Pogue J, Anand S: Waist circumference and waist-to-hip ratio as predictors of cardiovascular events: meta-regression analysis of prospective studies. Eur Heart J 2007, 28:850-856.
• [30]Folsom AR, Kushi LH, Anderson KE, Mink PJ, Olson JE, Hong CP, Sellers TA, Lazovich D, Prineas RJ: Associations of general and abdominal obesity with multiple health outcomes in older women: the Iowa Women’s Health Study. Arch Intern Med 2000, 160:2117-2128.
• [31]Feller S, Boeing H, Pischon T: Body mass index, waist circumference, and the risk of Type 2 diabetes mellitus: implications for routine clinical practice. Deutsches Arzteblatt Int 2010, 107:470-U24.
• [32]MacKay MF, Haffner SM, Wagenknecht LE, d’Agostino RB, Hanley AJG: Prediction of Type 2 diabetes using alternate anthropometric measures in a multi-ethnic cohort. Diabetes Care 2009, 32:956-958.
• [33]Marcadenti A, Fuchs SC, Moreira LB, Wiehe M, Gus M, Fuchs FD: Accuracy of anthropometric indexes of obesity to predict diabetes mellitus Type 2 among men and women with hypertension. Am J Hypertens 2011, 24:175-180.
• [34]Wang YF, Rimm EB, Stampfer MJ, Willett WC, Hu FB: Comparison of abdominal adiposity and overall obesity in predicting risk of type 2 diabetes among men. Am J Clin Nutr 2005, 81:555-563.
• [35]Cox BD, Whichelow MJ, Ashwell MA, Prevost AT: Comparison of anthropometric indices as predictors of mortality in British adults. Int J Obes Relat Metab Disord 1996, 20(Suppl 4):141.
• [36]Patel S, Unwin N, Bhopal R, White M, Harland J, Ayis SA, Watson W, Alberti KG: A comparison of proxy measures of abdominal obesity in Chinese, European and South Asian adults. Diabet Med 1999, 10:853-860.
• [37]Hsieh SD, Yoshinaga H, Muto T, Sakurai Y, Kosaka K: Health risks among Japanese men with moderate body mass index. Int J Obes Relat Metab Disord 2000, 24(3):358-362.
• [38]Hsieh SD, Yoshinaga H: Abdominal fat distribution and coronary heart disease risk factors in men: waist/height ratio as a simple and useful predictor. Int J Obes Relat Metab Disord 1995, 19:585-589.
• [39]Sayeed MA, Mahtab H, Latif ZA, Khanam PA, Ahsan KA, Banu A, Azad Khan AK: Waist-to-height ratio is a better obesity index than body mass index and waist-to-hip ratio for predicting diabetes, hypertension and lipidemia. Bangladesh Med Res Counc Bull 2003, 29(1):1-10.